Top Story

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014

Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites even when they had equal access to health care, according to study results presented at the American Association for Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved in San Antonio.

Marc A. Emerson, MPH, cancer research training award fellow in the division of cancer control and population sciences at the NCI, and colleagues used Kaiser Permanente Northern California electronic health records to collect data on 1,022 American Indians and Alaskan Natives diagnosed with primary invasive cancer between 1997 and 2012.

Jeffrey Kullgren, MD In the Journals

Lottery incentive improved fecal occult blood test completion rates

November 21, 2014
Among several different financial incentives tested, a lottery-style cash reward increased rates of completion of fecal occult blood tests for colon cancer screening…
In the Journals

Sorafenib/RFA therapy improved OS, recurrence rates in HCC

November 20, 2014
In a new study, patients with hepatocellular carcinoma who were treated with sorafenib plus radiofrequency ablation, or RFA, had increased overall survival and lower…
In the Journals

Adjuvant regimen improved outcomes in gastric cancer after D2 gastrectomy

November 19, 2014
Adjuvant treatment with capecitabine and oxaliplatin extended survival compared with observation among patients with stage II to stage IIIb gastric cancer who underwent…
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites…
Jeffrey Kullgren, MD In the Journals

Lottery incentive improved fecal occult blood test completion rates

November 21, 2014
Among several different financial incentives tested, a lottery-style cash reward increased rates of completion of fecal occult blood tests for colon…
In the Journals

Sorafenib/RFA therapy improved OS, recurrence rates in HCC

November 20, 2014
In a new study, patients with hepatocellular carcinoma who were treated with sorafenib plus radiofrequency ablation, or RFA, had increased overall…
In the Journals

Adjuvant regimen improved outcomes in gastric cancer after D2 gastrectomy

November 19, 2014
Adjuvant treatment with capecitabine and oxaliplatin extended survival compared with observation among patients with stage II to stage IIIb gastric…
FDA News

FDA grants fast track designation to MM-398 for metastatic pancreatic cancer

November 19, 2014
The FDA granted fast track designation to an investigational nanoliposomal irinotecan injection as a potential treatment for patients with metastatic…
Meeting News Coverage

Direct cost of care for HCC higher in patients with HCV who underwent liver transplant

November 18, 2014
BOSTON — Cost of care for hepatocellular carcinoma, or HCC, was higher among patients with HCC and hepatitis C virus infection who underwent…
In the Journals

Patients with lung, colon cancers often not informed about clinical trials

November 17, 2014
The majority of patients with newly diagnosed lung or colorectal cancers do not have discussions with their care team about clinical trial…

Novel tumor analysis technology made earlier diagnosis, predicted prognosis of bowel cancer

November 17, 2014
A novel imaging technology that analyzes tumor texture enabled earlier diagnosis compared with other tumor markers in patients with bowel cancer who…
In the Journals

Liver resection more cost-effective vs. transplantation for patients with HCC

November 17, 2014
In patients with hepatocellular carcinoma in the United States, Switzerland or Singapore, liver resection was more cost-effective than cadaveric…
In the Journals

S-1 plus oxiliplatin may be new first-line standard for advanced gastric cancer

November 14, 2014
Patients with advanced gastric cancer who underwent first-line treatment with S-1 plus oxaliplatin demonstrated comparable survival outcomes with…
More Headlines »
morganatic-roan